Cynata Therapeutics Ltd (CYP) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.969x

Based on the latest financial reports, Cynata Therapeutics Ltd (CYP) has a cash flow conversion efficiency ratio of -0.969x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.79 Million ≈ $-4.10 Million USD) by net assets (AU$5.98 Million ≈ $4.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CYP equity to assets ratio to measure how much of total assets are equity-financed.

Cynata Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Cynata Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore CYP cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cynata Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cynata Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Moleculin Biotech Inc NASDAQ:MBRX	-0.358x
Literacy Capital PLC LSE:BOOK	-0.008x
GlucoTrack Inc NASDAQ:GCTK	-1.392x
Club De Futbol Intercity Sad MC:CITY	0.745x
Kiplin Metals Inc V:KIP	-0.072x
Hexima Ltd AU:HXL	-0.081x
Cascadero Copper Corp V:CCD	0.082x
Grosvenor Resource Corp V:GVR	-0.811x

Annual Cash Flow Conversion Efficiency for Cynata Therapeutics Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Cynata Therapeutics Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see CYP market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$5.98 Million ≈ $4.23 Million	AU$-8.72 Million ≈ $-6.17 Million	-1.458x	-5.63%
2024-06-30	AU$7.22 Million ≈ $5.11 Million	AU$-9.96 Million ≈ $-7.05 Million	-1.380x	-61.69%
2023-06-30	AU$16.73 Million ≈ $11.84 Million	AU$-14.28 Million ≈ $-10.11 Million	-0.854x	-520.04%
2022-06-30	AU$23.96 Million ≈ $16.95 Million	AU$-3.30 Million ≈ $-2.33 Million	-0.138x	+24.35%
2021-06-30	AU$28.37 Million ≈ $20.08 Million	AU$-5.16 Million ≈ $-3.65 Million	-0.182x	+9.81%
2020-06-30	AU$16.79 Million ≈ $11.88 Million	AU$-3.39 Million ≈ $-2.40 Million	-0.202x	+67.25%
2019-06-30	AU$10.97 Million ≈ $7.76 Million	AU$-6.76 Million ≈ $-4.78 Million	-0.616x	-133.37%
2018-06-30	AU$15.39 Million ≈ $10.89 Million	AU$-4.06 Million ≈ $-2.87 Million	-0.264x	+9.59%
2017-06-30	AU$13.86 Million ≈ $9.81 Million	AU$-4.05 Million ≈ $-2.86 Million	-0.292x	+42.44%
2016-06-30	AU$8.58 Million ≈ $6.07 Million	AU$-4.35 Million ≈ $-3.08 Million	-0.507x	-70.56%
2015-06-30	AU$8.75 Million ≈ $6.19 Million	AU$-2.60 Million ≈ $-1.84 Million	-0.297x	-58.11%
2014-06-30	AU$9.85 Million ≈ $6.97 Million	AU$-1.85 Million ≈ $-1.31 Million	-0.188x	+59.64%
2013-06-30	AU$1.64 Million ≈ $1.16 Million	AU$-765.76K ≈ $-541.83K	-0.466x	+45.44%
2012-06-30	AU$853.75K ≈ $604.08K	AU$-729.33K ≈ $-516.05K	-0.854x	+68.73%
2011-06-30	AU$971.93K ≈ $687.70K	AU$-2.66 Million ≈ $-1.88 Million	-2.732x	-30.36%
2010-06-30	AU$932.00K ≈ $659.45K	AU$-1.95 Million ≈ $-1.38 Million	-2.096x	-65.58%
2009-06-30	AU$961.98K ≈ $680.66K	AU$-1.22 Million ≈ $-861.47K	-1.266x	-94.87%
2008-06-30	AU$2.21 Million ≈ $1.56 Million	AU$-1.44 Million ≈ $-1.02 Million	-0.649x	--

About Cynata Therapeutics Ltd

AU:CYP Australia Biotechnology

Market Cap

$2.18 Million

AU$3.09 Million AUD

Market Cap Rank

#29893 Global

#1740 in Australia

Share Price

AU$0.01

Change (1 day)

+8.33%

52-Week Range

AU$0.01 - AU$0.40

All Time High

AU$1.84